Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.
The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Infliximab Biosimilar market competitiveness, regional economic interdependencies, and supply chain reconfigurations.
Infliximab Biosimilar Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.
Infliximab Biosimilar Market by Type [Analysis by Value from 2020 to ]:
- IV infusions
- Subcutaneous injections
- Autoimmune drugs
Infliximab Biosimilar Market by Application [Analysis by Value from 2020 to ]:
- Rheumatoid arthritis
- Crohn’s disease
- Ulcerative colitis
- Psoriasis
Key Players in the Infliximab Biosimilar Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
{playerNamesList}
Infliximab Biosimilar Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.
Infliximab Biosimilar Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.
Infliximab Biosimilar Market Size & Demand Forecast ()
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.
Infliximab Biosimilar Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.
Infliximab Biosimilar Segmentation & Growth Forecasts
The study systematically breaks down the Global Infliximab Biosimilar Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.
Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)
Competitive Landscape & Key Player Profiles
Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders
Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.
Why Invest in This Infliximab Biosimilar Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Infliximab Biosimilar market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.
For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.
1 Market Overview
1.1 Infliximab Biosimilar Definition
1.2 Global Infliximab Biosimilar Market Size and Forecast
1.2.1 By Revenue, Global Infliximab Biosimilar Market Size, 2019-2030
1.2.2 By Sales Volume, Global Infliximab Biosimilar Market Size, 2019-2030
1.2.3 Global Infliximab Biosimilar Price Trend, 2019-2030
1.3 China Infliximab Biosimilar Market Size and Forecast
1.3.1 By Revenue, China Infliximab Biosimilar Market Size, 2019-2030
1.3.2 By Sales Volume, China Infliximab Biosimilar Market Size, 2019-2030
1.3.3 China Infliximab Biosimilar Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Infliximab Biosimilar Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Infliximab Biosimilar Share in Global Market, 2019-2030
1.4.3 Infliximab Biosimilar Market Size: China VS Global, 2019-2030
1.5 Infliximab Biosimilar Market Dynamics
1.5.1 Infliximab Biosimilar Market Drivers
1.5.2 Infliximab Biosimilar Market Restraints
1.5.3 Infliximab Biosimilar Industry Trends
1.5.4 Infliximab Biosimilar Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Infliximab Biosimilar Revenue by Company, 2019-2023
2.2 Global Infliximab Biosimilar Sales Volume by Company, 2019-2023
2.3 Global Infliximab Biosimilar Price by Company, 2019-2023
2.4 Global Infliximab Biosimilar Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Infliximab Biosimilar Concentration Ratio
2.6 Global Infliximab Biosimilar Mergers & Acquisitions, Expansion Plans
2.7 Global Infliximab Biosimilar Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Infliximab Biosimilar Revenue by Company, 2019-2023
3.2 China Infliximab Biosimilar Sales Volume by Company, 2019-2023
3.3 China Infliximab Biosimilar Infliximab Biosimilar Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Infliximab Biosimilar Market, Sales Percentage of Local Players VS Foreign Players (2019-2023)
3.5 Chinese Local Players, Infliximab Biosimilar Domestic VS Export
3.6 China Market, Infliximab Biosimilar Import & Export
3.6.1 China Market, Infliximab Biosimilar Import & Export, 2019-2030
3.6.2 China Infliximab Biosimilar Import & Export Trends
3.6.3 Main Sources of China Infliximab Biosimilar Import
3.6.4 Export Destination of China Infliximab Biosimilar
4 Infliximab Biosimilar Production by Region
4.1 Global Infliximab Biosimilar Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Infliximab Biosimilar Manufacturers
4.3 Global Major Manufacturers, Infliximab Biosimilar Capacity Expansion and Future Plans
4.4 Global Infliximab Biosimilar Capacity by Region
4.5 Global Infliximab Biosimilar Production by Region
4.5.1 Global Infliximab Biosimilar Production & Forecast by Region, 2019 VS 2023 VS 2030
4.5.2 Global Infliximab Biosimilar Production by Region, 2019-2023
4.5.3 Global Infliximab Biosimilar Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Infliximab Biosimilar Industry Chain
5.2 Infliximab Biosimilar Upstream Analysis
5.2.1 Infliximab Biosimilar Core Raw Materials
5.2.2 Main Manufacturers of Infliximab Biosimilar Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Infliximab Biosimilar Production Mode
5.6 Infliximab Biosimilar Procurement Model
5.7 Infliximab Biosimilar Industry Sales Model and Sales Channels
5.7.1 Infliximab Biosimilar Sales Model
5.7.2 Infliximab Biosimilar Typical Distributors
6 Sights by Type
6.1 Infliximab Biosimilar Classification
6.1.1 CT-P13/infliximab-dyyb
6.1.2 Remsima
6.1.3 Inflectra
6.2 By Type, Global Infliximab Biosimilar Market Size & CAGR, 2019 VS 2023 VS 2030
6.3 By Type, Global Infliximab Biosimilar Revenue, 2019-2030
6.4 By Type, Global Infliximab Biosimilar Sales Volume, 2019-2030
6.5 By Type, Global Infliximab Biosimilar Price, 2019-2030
7 Sights by Application
7.1 Infliximab Biosimilar Segment by Application
7.1.1 Crohn's Disease
7.1.2 Rheumatoid Arthritis
7.1.3 Ulcerative Colitis
7.1.4 Ankylosing Spondylitis
7.1.5 Plaque Psoriasis
7.1.6 Others
7.2 By Application, Global Infliximab Biosimilar Market Size & CAGR, 2019 VS 2023 VS 2030
7.3 By Application, Global Infliximab Biosimilar Revenue, 2019-2030
7.4 By Application, Global Infliximab Biosimilar Sales Volume, 2019-2030
7.5 By Application, Global Infliximab Biosimilar Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Infliximab Biosimilar Market Size, 2019 VS 2023 VS 2030
8.2 By Region, Global Infliximab Biosimilar Revenue, 2019-2030
8.3 By Region, Global Infliximab Biosimilar Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Infliximab Biosimilar Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Infliximab Biosimilar Market Size Market Share
8.5 Europe
8.5.1 Europe Infliximab Biosimilar Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Infliximab Biosimilar Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Infliximab Biosimilar Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Infliximab Biosimilar Market Size Market Share
8.7 South America
8.7.1 South America Infliximab Biosimilar Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Infliximab Biosimilar Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Infliximab Biosimilar Market Size & CAGR,2019 VS 2023 VS 2030
9.2 By Country, Global Infliximab Biosimilar Revenue, 2019-2030
9.3 By Country, Global Infliximab Biosimilar Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Infliximab Biosimilar Market Size, 2019-2030
9.4.2 By Company, U.S. Infliximab Biosimilar Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Infliximab Biosimilar Market Size, 2019-2030
9.5.2 By Company, Europe Infliximab Biosimilar Sales Volume Market Share, 2023
9.5.3 By Type, Europe Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Infliximab Biosimilar Market Size, 2019-2030
9.6.2 By Company, China Infliximab Biosimilar Sales Volume Market Share, 2023
9.6.3 By Type, China Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Infliximab Biosimilar Market Size, 2019-2030
9.7.2 By Company, Japan Infliximab Biosimilar Sales Volume Market Share, 2023
9.7.3 By Type, Japan Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Infliximab Biosimilar Market Size, 2019-2030
9.8.2 By Company, South Korea Infliximab Biosimilar Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Infliximab Biosimilar Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Infliximab Biosimilar Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Infliximab Biosimilar Market Size, 2019-2030
9.10.2 By Company, India Infliximab Biosimilar Sales Volume Market Share, 2023
9.10.3 By Type, India Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Infliximab Biosimilar Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Infliximab Biosimilar Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Infliximab Biosimilar Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Infliximab Biosimilar Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Napp Pharmaceuticals Group
10.1.1 Napp Pharmaceuticals Group Company Information, Head Office, Market Area and Industry Position
10.1.2 Napp Pharmaceuticals Group Infliximab Biosimilar Models, Specifications and Application
10.1.3 Napp Pharmaceuticals Group Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.1.4 Napp Pharmaceuticals Group Company Profile and Main Business
10.1.5 Napp Pharmaceuticals Group Recent Developments
10.2 Janssen Biotech
10.2.1 Janssen Biotech Company Information, Head Office, Market Area and Industry Position
10.2.2 Janssen Biotech Infliximab Biosimilar Models, Specifications and Application
10.2.3 Janssen Biotech Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.2.4 Janssen Biotech Company Profile and Main Business
10.2.5 Janssen Biotech Recent Developments
10.3 Alvogen
10.3.1 Alvogen Company Information, Head Office, Market Area and Industry Position
10.3.2 Alvogen Infliximab Biosimilar Models, Specifications and Application
10.3.3 Alvogen Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.3.4 Alvogen Company Profile and Main Business
10.3.5 Alvogen Recent Developments
10.4 Merck
10.4.1 Merck Company Information, Head Office, Market Area and Industry Position
10.4.2 Merck Infliximab Biosimilar Models, Specifications and Application
10.4.3 Merck Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.4.4 Merck Company Profile and Main Business
10.4.5 Merck Recent Developments
10.5 Celltrion
10.5.1 Celltrion Company Information, Head Office, Market Area and Industry Position
10.5.2 Celltrion Infliximab Biosimilar Models, Specifications and Application
10.5.3 Celltrion Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.5.4 Celltrion Company Profile and Main Business
10.5.5 Celltrion Recent Developments
10.6 Pfizer(Ac Hospira)
10.6.1 Pfizer(Ac Hospira) Company Information, Head Office, Market Area and Industry Position
10.6.2 Pfizer(Ac Hospira) Infliximab Biosimilar Models, Specifications and Application
10.6.3 Pfizer(Ac Hospira) Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.6.4 Pfizer(Ac Hospira) Company Profile and Main Business
10.6.5 Pfizer(Ac Hospira) Recent Developments
10.7 Nippon Kayaku
10.7.1 Nippon Kayaku Company Information, Head Office, Market Area and Industry Position
10.7.2 Nippon Kayaku Infliximab Biosimilar Models, Specifications and Application
10.7.3 Nippon Kayaku Infliximab Biosimilar Sales Volume, Revenue, Price and Gross Margin, 2019-2023
10.7.4 Nippon Kayaku Company Profile and Main Business
10.7.5 Nippon Kayaku Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Infliximab Biosimilar Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Infliximab Biosimilar Market Restraints
Table 3. Infliximab Biosimilar Market Trends
Table 4. Infliximab Biosimilar Industry Policy
Table 5. Global Infliximab Biosimilar Revenue by Company, 2019-2023, US$ million
Table 6. Global Infliximab Biosimilar Revenue Market Share by Company, 2019-2023
Table 7. Global Infliximab Biosimilar Sales Volume by Company, 2019-2023, (K Units)
Table 8. Global Infliximab Biosimilar Sales Volume Market Share by Company, 2019-2023
Table 9. Global Infliximab Biosimilar Price by Company, 2019-2023, (US$/Unit)
Table 10. Global Infliximab Biosimilar Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Infliximab Biosimilar Mergers & Acquisitions, Expansion Plans
Table 12. Global Infliximab Biosimilar Manufacturers Product Type
Table 13. China Infliximab Biosimilar Revenue by Company, 2019-2023, US$ million
Table 14. China Infliximab Biosimilar Revenue Market Share by Company, 2019-2023
Table 15. China Infliximab Biosimilar Sales Volume by Company, 2019-2023, (K Units)
Table 16. China Infliximab Biosimilar Sales Volume Market Share by Company, 2019-2023
Table 17. China Market, Infliximab Biosimilar Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Infliximab Biosimilar Import & Export Trends
Table 19. Main Sources of China Infliximab Biosimilar Import
Table 20. Export Destination of China Infliximab Biosimilar
Table 21. Global Headquarters and Manufacturing Base of Infliximab Biosimilar Manufacturers
Table 22. Global Major Manufacturers, Infliximab Biosimilar Capacity Expansion and Future Plans
Table 23. Global Infliximab Biosimilar Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)
Table 24. Global Infliximab Biosimilar Production by Region, 2019-2023, (K Units)
Table 25. Global Infliximab Biosimilar Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Infliximab Biosimilar Upstream (Raw Materials)
Table 27. Global Infliximab Biosimilar Typical Customers
Table 28. Infliximab Biosimilar Typical Distributors
Table 29. By Type, Global Infliximab Biosimilar Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million
Table 30. By Application, Global Infliximab Biosimilar Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million
Table 31. By Region, Global Infliximab Biosimilar Market Size, 2019 VS 2023 VS 2030, US$ Million
Table 32. By Region, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Infliximab Biosimilar Revenue & CAGR,2019 VS 2023 VS 2030, US$ Million
Table 35. By Country, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Infliximab Biosimilar Revenue Market Share, 2019-2030
Table 37. By Country, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030
Table 39. Napp Pharmaceuticals Group Company Information, Head Office, Market Area and Industry Position
Table 40. Napp Pharmaceuticals Group Infliximab Biosimilar Models, Specifications and Application
Table 41. Napp Pharmaceuticals Group Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 42. Napp Pharmaceuticals Group Company Profile and Main Business
Table 43. Napp Pharmaceuticals Group Recent Developments
Table 44. Janssen Biotech Company Information, Head Office, Market Area and Industry Position
Table 45. Janssen Biotech Infliximab Biosimilar Models, Specifications and Application
Table 46. Janssen Biotech Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 47. Janssen Biotech Company Profile and Main Business
Table 48. Janssen Biotech Recent Developments
Table 49. Alvogen Company Information, Head Office, Market Area and Industry Position
Table 50. Alvogen Infliximab Biosimilar Models, Specifications and Application
Table 51. Alvogen Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 52. Alvogen Company Profile and Main Business
Table 53. Alvogen Recent Developments
Table 54. Merck Company Information, Head Office, Market Area and Industry Position
Table 55. Merck Infliximab Biosimilar Models, Specifications and Application
Table 56. Merck Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 57. Merck Company Profile and Main Business
Table 58. Merck Recent Developments
Table 59. Celltrion Company Information, Head Office, Market Area and Industry Position
Table 60. Celltrion Infliximab Biosimilar Models, Specifications and Application
Table 61. Celltrion Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 62. Celltrion Company Profile and Main Business
Table 63. Celltrion Recent Developments
Table 64. Pfizer(Ac Hospira) Company Information, Head Office, Market Area and Industry Position
Table 65. Pfizer(Ac Hospira) Infliximab Biosimilar Models, Specifications and Application
Table 66. Pfizer(Ac Hospira) Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 67. Pfizer(Ac Hospira) Company Profile and Main Business
Table 68. Pfizer(Ac Hospira) Recent Developments
Table 69. Nippon Kayaku Company Information, Head Office, Market Area and Industry Position
Table 70. Nippon Kayaku Infliximab Biosimilar Models, Specifications and Application
Table 71. Nippon Kayaku Infliximab Biosimilar Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023
Table 72. Nippon Kayaku Company Profile and Main Business
Table 73. Nippon Kayaku Recent Developments
List of Figure
Figure 1. Infliximab Biosimilar Picture
Figure 2. By Revenue, Global Infliximab Biosimilar Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Infliximab Biosimilar Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Infliximab Biosimilar Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Infliximab Biosimilar Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Infliximab Biosimilar Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Infliximab Biosimilar Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Infliximab Biosimilar Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Infliximab Biosimilar Share of Global Market, 2019-2030
Figure 10. Global Infliximab Biosimilar Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 11. Global Infliximab Biosimilar Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023
Figure 12. China Infliximab Biosimilar Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 13. China Infliximab Biosimilar Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 14. China Infliximab Biosimilar Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023
Figure 15. Chinese Local Players, Proportion of Infliximab Biosimilar Domestic VS Export, 2023
Figure 16. Global Infliximab Biosimilar Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Infliximab Biosimilar Capacity Market Share by Region, 2023 VS 2030
Figure 18. Global Infliximab Biosimilar Production Market Share & Forecast by Region, 2019-2030
Figure 19. Infliximab Biosimilar Industry Chain
Figure 20. Infliximab Biosimilar Procurement Model
Figure 21. Infliximab Biosimilar Sales Model
Figure 22. Infliximab Biosimilar Sales Channels, Direct Sales and Distribution
Figure 23. CT-P13/infliximab-dyyb
Figure 24. Remsima
Figure 25. Inflectra
Figure 26. By Type, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million
Figure 27. By Type, Global Infliximab Biosimilar Revenue Market Share, 2019-2030
Figure 28. By Type, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 29. By Type, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030
Figure 30. By Type, Global Infliximab Biosimilar Price, 2019-2030, (US$/Unit)
Figure 31. Crohn's Disease
Figure 32. Rheumatoid Arthritis
Figure 33. Ulcerative Colitis
Figure 34. Ankylosing Spondylitis
Figure 35. Plaque Psoriasis
Figure 36. Others
Figure 37. By Application, Global Infliximab Biosimilar Revenue, 2019-2030, US$ Million
Figure 38. By Application, Global Infliximab Biosimilar Revenue Market Share, 2019-2030
Figure 39. By Application, Global Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 40. By Application, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030
Figure 41. By Application, Global Infliximab Biosimilar Price, 2019-2030, (US$/Unit)
Figure 42. By Region, Global Infliximab Biosimilar Revenue Market Share, 2019-2030
Figure 43. By Region, Global Infliximab Biosimilar Sales Volume Market Share, 2019-2030
Figure 44. North America Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country, North America Infliximab Biosimilar Revenue Market Share, 2023
Figure 46. Europe Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, Europe Infliximab Biosimilar Revenue Market Share, 2023
Figure 48. Asia Pacific Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. By Country/Region, Asia Pacific Infliximab Biosimilar Revenue Market Share, 2023
Figure 50. South America Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million
Figure 51. By Country, South America Infliximab Biosimilar Revenue Market Share, 2023
Figure 52. Middle East & Africa Infliximab Biosimilar Revenue & Forecasts, 2019-2030, US$ Million
Figure 53. U.S. Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 54. By Company, U.S. Infliximab Biosimilar Market Share, 2023
Figure 55. By Type, U.S. Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 56. By Application, U.S. Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 57. Europe Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 58. By Company, Europe Infliximab Biosimilar Market Share, 2023
Figure 59. By Type, Europe Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 60. By Application, Europe Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 61. China Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 62. By Company, China Infliximab Biosimilar Market Share, 2023
Figure 63. By Type, China Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 64. By Application, China Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 65. Japan Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 66. By Company, Japan Infliximab Biosimilar Market Share, 2023
Figure 67. By Type, Japan Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 68. By Application, Japan Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 69. South Korea Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 70. By Company, South Korea Infliximab Biosimilar Market Share, 2023
Figure 71. By Type, South Korea Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 72. By Application, South Korea Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 73. Southeast Asia Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 74. By Company, Southeast Asia Infliximab Biosimilar Market Share, 2023
Figure 75. By Type, Southeast Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 76. By Application, Southeast Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 77. India Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 78. By Company, India Infliximab Biosimilar Market Share, 2023
Figure 79. By Type, India Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 80. By Application, India Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 81. Middle East & Asia Infliximab Biosimilar Sales Volume, 2019-2030, (K Units)
Figure 82. By Company, Middle East & Asia Infliximab Biosimilar Market Share, 2023
Figure 83. By Type, Middle East & Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 84. By Application, Middle East & Asia Infliximab Biosimilar Sales Volume Market Share, 2023 VS 2030
Figure 85. Research Methodology
Figure 86. Breakdown of Primary Interviews
Figure 87. Bottom-up Approaches
Figure 88. Top-down Approaches
Research Methodology:
Infliximab Biosimilar Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|